class action lawsuit

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about CELLECTRA device manufacturing and INO-3107 FDA submission timeline between October 2023 and December 2025.

Class action lawsuit filed against $TCPC alleging false statements on valuations and NAV during November 2024-January 2026 period. Investors have until April 6, 2026 to act.

Class action filed against Masonite alleging undisclosed Owens Corning acquisition offers while company repurchased stock at depressed prices.

Soleno Therapeutics faces class action lawsuit alleging failure to disclose safety concerns about DCCR drug candidate from clinical trials.

Class action filed against $PMI alleging securities fraud, false promotion, and insider share dumping via offshore accounts. Investors have until April 2026 to join.

Class action lawsuit filed against $VTGN alleges securities fraud over misleading statements about fasedienol drug candidate and PALISADE-3 clinical trial data.

DJS Law Group files class action against $DRVN over alleged false statements regarding revenue overstatement and expense understatement in consolidated balance sheet.

Paysafe faces securities fraud class action over undisclosed high-risk merchant exposure and understated credit reserves. Investors have until April 7, 2026 to join.

Class action lawsuit filed against $CWH alleging false statements about inventory management capabilities, claiming misleading public disclosures harmed shareholders.

$DRVN faces class action lawsuit alleging revenue overstatement, overstated cash, and understated expenses from May 2023 through February 2026. Shareholders have until May 8, 2026 to join.

Schall Law Firm seeks lead plaintiffs for securities fraud lawsuit against Richtech Robotics ($RR) over alleged false Microsoft partnership claims.

Paysafe ($PSFE) faces class action lawsuit alleging securities fraud over hidden credit exposure and missed fiscal 2025 guidance. Investors have until April 7, 2026 to join.

DJS Law Group filed class action against $RR for securities violations, alleging false Microsoft partnership statements during January 27-29, 2026 period.

Ultragenyx Pharmaceutical's stock plunged 42% after failing to disclose setrusumab Phase 3 trial failure, triggering securities litigation with April 6, 2026 lead plaintiff deadline.

Rosen Law Firm investigates KDDI for allegedly misleading investors. Stock fell 11.4% after company postponed earnings disclosure due to internal investigation.

Nidec stock plunges 22.7% after announcing China accounting probe; law firms investigating securities fraud claims for affected investors.

Hub Group discloses accounting error understating costs, triggering 18.3% stock plunge and securities litigation investigation.

Kyndryl Holdings faces securities class action over undisclosed internal control weaknesses. Stock plunged 55% after February 2026 disclosure; lead plaintiff deadline set for April 13.

Enphase Energy faces class action lawsuit over alleged material misstatements regarding inventory management and tax credit impacts. Lead plaintiff deadline set for April 20, 2026.

$CORT stock plummets 50% after FDA rejects lead drug relacorilant; class action targets alleged disclosure failures with lead plaintiff deadline April 21, 2026.